Einat Brill Almon
Overview
Einat Brill Almon received an average of $605K in total compensation, including $235K in salary, at Protalix BioTherapeutics from 2006 to 2021.
2021Protalix BioTherapeuticsSenior Vice President, Chief Development Officer
2020Protalix BioTherapeuticsSenior Vice President, Chief Development Officer
2019Protalix BioTherapeuticsSenior Vice President, Product Development
2018Protalix BioTherapeuticsSenior Vice President, Product Development
2017Protalix BioTherapeuticsSenior Vice President, Product Development
2016Protalix BioTherapeuticsSenior Vice President, Product Development
2015Protalix BioTherapeuticsSenior Vice President, Product Development
2014Protalix BioTherapeuticsSenior Vice President, Product Development
2013Protalix BioTherapeuticsSenior Vice President, Product Development
2012Protalix BioTherapeuticsSenior Vice President, Product Development
Source: SEC filings on April 29, 2022, April 15, 2020, April 12, 2019, March 6, 2018, March 16, 2017, July 1, 2016, October 9, 2014, September 19, 2013, May 21, 2012, September 19, 2011, September 17, 2009, and October 3, 2008.
Related executives
We found ten more executives who work or worked at Protalix BioTherapeutics.
Dror Bashan
Protalix BioTherapeutics
Chief Executive Officer
Eyal Rubin
Protalix BioTherapeutics
Chief Financial Officer
Yaron Naos
Protalix BioTherapeutics
Senior Vice President, Operations
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
Tzvi Palash
Protalix BioTherapeutics
Chief Operating Officer
David Aviezer
Protalix BioTherapeutics